Skip to content

Medical-device intelligence

Siemens Healthcare Diagnostics Inc: FDA clearances and recalls

Research Siemens Healthcare Diagnostics Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

154 clearance records and 730 recall records in the covered releases, across 1 source company names and 160 product codes. Dated history runs from Mar 2, 2007 to Nov 6, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202513
November 202500
December 202510
January 202611
February 202621
March 202601
April 202601
May 202601
June 202603
July 202613
August 202611
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

884 matching records
Device / recordCompany in FDA recordSourceSource date
ADVIA Centaur Erythropoietin (EPO) Assay (100 Test)Z-1281-2024 · GGTSiemens Healthcare Diagnostics, Inc.RecallMar 11, 2024FDA classification date
Total immunoglobulin M (IgM total) IVD, kit, nephelometry/turbidimetryZ-1003-2024 · CFNSiemens Healthcare Diagnostics, Inc.RecallFeb 7, 2024FDA classification date
Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)K233242 · NQDSiemens Healthcare Diagnostics, Inc.510(k)Jan 18, 2024FDA decision date
epoc NXS Host Blood Analysis System, Siemens Material Numbers 11413497 (EU), 11413475 (US), 11413506 (CA), 11413517 (MX), 11413518 (ROW), 1141349…Z-0601-2024 · CHLSiemens Healthcare Diagnostics IncRecallDec 21, 2023FDA classification date
RAPIDPoint 500 Systems Measurement Cartridge (with Lactate) 100 -Intended for in vitro diagnostic use and is designed to provide the determinati…Z-0606-2024 · JIXSiemens Healthcare Diagnostics IncRecallDec 21, 2023FDA classification date
RAPIDPoint 500 Systems Measurement Cartridge (with Lactate) 250-Intended for in vitro diagnostic use and is designed to provide the determination…Z-0607-2024 · JIXSiemens Healthcare Diagnostics IncRecallDec 21, 2023FDA classification date
RAPIDPoint 500 Systems Measurement Cartridge (with Lactate) 400-Intended for in vitro diagnostic use and is designed to provide the determination…Z-0608-2024 · JIXSiemens Healthcare Diagnostics IncRecallDec 21, 2023FDA classification date
RAPIDPoint 500 Systems Measurement Cartridge (with Lactate) 750-Intended for in vitro diagnostic use and is designed to provide the determination…Z-0609-2024 · JIXSiemens Healthcare Diagnostics IncRecallDec 21, 2023FDA classification date
RAPIDPOINT 500e Blood Gas SystemZ-0422-2024 · JGSSiemens Healthcare Diagnostics IncRecallDec 1, 2023FDA classification date
RAPIDPOINT 500 Blood Gas SystemZ-0423-2024 · JGSSiemens Healthcare Diagnostics IncRecallDec 1, 2023FDA classification date
ADVIA Chemistry Iron_2 (IRON_2) Reagents, Material Numbers 10377510 (6 x 350 tests) and 10341118 (7 x 145 tests)Z-2666-2023 · CDQSiemens Healthcare Diagnostics, Inc.RecallSep 30, 2023FDA classification date
ADVIA Centaur® NT-proBNPII (PBNPII)K220265 · NBCSiemens Healthcare Diagnostics, Inc.510(k)Sep 24, 2023FDA decision date
Atellica CH LDL Cholesterol Direct (DLDL)-In vitro diagnostic quantitative determination of LDL cholesterol in human serum and plasma (lithium he…Z-1268-2023 · MRRSiemens Healthcare Diagnostics, Inc.RecallAug 29, 2023FDA classification date
Atellica CH Total Protein II- In vitro diagnostic use in the quantitative determination of total protein in human serum and plasma (lithium hepar…Z-1269-2023 · CEKSiemens Healthcare Diagnostics, Inc.RecallAug 29, 2023FDA classification date
Atellica CH Triglycerides (concentrated)-In vitro diagnostic use in the quantitative measurement of triglycerides in human serum and plasma (lith…Z-1270-2023 · CDTSiemens Healthcare Diagnostics, Inc.RecallAug 29, 2023FDA classification date
Atellica CH Triglycerides_2: in vitro diagnostic use in the quantitative determination of triglycerides in human serum and plasma (lithium hepari…Z-1271-2023 · CDTSiemens Healthcare Diagnostics, Inc.RecallAug 29, 2023FDA classification date
Atellica CH Total Bilirubin_2 -In vitro diagnostic use in the quantitative determination of total bilirubin in human serum and plasma (lithium he…Z-2471-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH LDL Cholesterol- In vitro diagnostic use in the quantitative determination of LDL cholesterol in human serum and plasma (lithium hepa…Z-2472-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH Gamma-Glutamyl Transferase-IIn vitro diagnostic use in the quantitative determination of gamma-glutamyl transferase in human serum an…Z-2473-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
Atellica CH HDL Cholesterol- In vitro diagnostic use in the quantitative determination of HDL cholesterol in human serum and plasma (lithium hep…Z-2474-2023 · JFMSiemens Healthcare Diagnostics, Inc.RecallAug 28, 2023FDA classification date
epoc BGEM BUN Test Card with epoc Host SW v3.37.3, epoc NXS SW v4.10.6, Sensor Configuration 41.1Z-2476-2023 · CHLSiemens Healthcare Diagnostics IncRecallAug 28, 2023FDA classification date
epoc BGEM Crea Test Card with epoc Host SW v3.37.3, epoc NXS SW v4.10.6, Sensor Configuration 41.1Z-2477-2023 · CHLSiemens Healthcare Diagnostics IncRecallAug 28, 2023FDA classification date
epoc BGEM Test Card (BUN & TCO2),Veterinary with epoc Host SW v3.37.3, epoc NXS SW v4.10.6, Sensor Configuration 41.1Z-2478-2023 · CHLSiemens Healthcare Diagnostics IncRecallAug 28, 2023FDA classification date
ADVIA Chemistry Urinary/Cerebrospinal Fluid Protein (UCFP), Material Number 11319151, in vitro diagnostic use in the quantitative determination …Z-2451-2023 · JITSiemens Healthcare Diagnostics, Inc.RecallAug 24, 2023FDA classification date
Atellica® CH Phencyclidine (Pcp), Atellica® CH Vancomycin (Vanc)K222439 · LEHSiemens Healthcare Diagnostics, Inc.510(k)Aug 8, 2023FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗